162 Halkitis, P.N., Parsons, J.T., & Stirratt, M.J. (2001). A double epidemic: Crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality, 41, 17-35. Hall, W., Darke, S., Ross, M. & Wodak, A. (1993). Patterns of drug use and risk-taking among injecting amphetamine and opioid users in Sydney, Australia. Addiction, 88(4), 509-516. Hall, W., Hando, J., Darke, S., & Ross, J. (1996). Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction, 91, 81-87. Haller, J., Makara, G.B., & Kruk, M.R. (1998). Catecholaminergic involvement in the control of aggression: Hormones, the peripheral sympathetic, and central noradrenergic systems. Neurosciences and Biobehavioral Reviews, 22, 85-97. Hammersley, R., Khan, F., & Ditton, J. (2002). Ecstasy and the Rise of the Chemical Generation. London and New York: Routledge. Hando, J. & Hall, W. (1997). Patterns of amphetamine use in Australia. In H. Klee (Ed.), <strong>Amphetamine</strong> Misuse: International Perspectives on Current Trends. The Netherlands: Harwood Academic Publishers. Hando, J., Hall, W., Rutter, S. & Dolan, K. (1999). Current State of Research on Illicit Drugs in Australia. Canberra: NH&MRC. Hando, J., Topp, L. & Dillon, P. (1998). Ecstasy use in Sydney II: Associated harms and risk taking behaviour. In P.Dillon, L.Topp & W.Swift (Eds.), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh <strong>National</strong> Drug and Alcohol Research Centre Annual Symposium. Sydney: <strong>National</strong> Drug and Alcohol Research Centre. Hando, J., Topp, L. & Hall, W. (1997). <strong>Amphetamine</strong>-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence, 46, 105-113. Harris, C. (2007). Drugs and Alcohol in the Workplace. Australian Chamber of Commerce and Industry. Issues <strong>Paper</strong>. Hatzipetros, T., Raudensky, J.G., Soghomonian, J., & Yamamoto, B.K. (2007). Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata. Journal of Neuroscience, 27 (22), 5895-5902. Hawke, J.M., Jainchill, N. & de Leon, G. (2000). Adolescent amphetamine users in treatment: Client profiles and treatment outcomes. Journal of Psychoactive Drugs, 32 (1), 95-105. Heffernan, E.B. (2006). Methamphetamines and mental illness. Presentation at Australasian <strong>Amphetamine</strong> Conference: Sydney, Australia. Heffernan, E.B., Finn, J., Saunders, J.B., & Byrne, G. (2003). Substance-use disorders and psychological distress among police detainees. Medical Journal of Australia, 179, 408- 411.
163 Hegadoren, K.M., Baker, G.B., & Bourin, M. (1999). 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans. Neuroscience Biobehavioural Review, 23, 539-553. Henry-Edwards, S. (2001). Psychostimulants in Australia. Unpublished paper prepared on behalf of the <strong>National</strong> Expert Advisory Committee on Illicit Drugs. Herman-Stahl, M.A., Krebs, C.P., Kroutil, L.A. & Heller, D.C. (2007). Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addictive Behaviors, 32, 1003-1015. Hillhouse, M.P., Marinelli-Casey, P., Gonzales, R., Ang, A., Rawson, R.A. and the Methamphetamine Treatment Project Corporate Authors. (2007). Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction, 102 (Suppl. 1), 84-95. Hillier, L., de Visser, R., Kavanagh, A. & McNair, R. (2003). The association between licit and illicit drug use and sexuality in young Australian women. Medical Journal of Australia, 179(6), 326-327. Hillier, L., Turner, A. & Mitchell, A. (2005). Writing themselves in again - six years on: the second national report on the sexuality, health and well-being of same sex attracted young people. Melbourne: Australian Research Centre in Sex Health and Society, La Trobe University. Homel, P. & Willis, K. (2007) A framework for measuring the performance of drug law enforcement. Trends and Issues in Crime and Criminal Justice, No. 332. Canberra: Australian Institute of Criminology. Horton, D.K., Berkowitz, Z., & Kaye, W.E. (2003). The acute health consequences to children exposed to hazardous substances used in illicit methamphetamine production. 1996- 2001. Journal of Child Health, 1, 99-108. Hser, Y., Evans, E., Huang, Y.C. (2005). Treatment outcomes among women and men methamphetamine abusers in California. Journal Substance Abuse Treatment, 28, 77-85. Hull, P., Brown, G., Rawstorne, P., Prestage, G., Kippax, S. & Langdon, T. (2005). Gay community Periodic Survey Perth 2004. <strong>National</strong> Centre in HIV Social Research, <strong>National</strong> Centre in HIV Epidemiology and Clinical Research, Western Australian Centre for Health Promotion Research and Western Australia AIDS Council, <strong>National</strong> Centre in HIV Social Research. Hull, P., Prestage, G., Rawstorne, P., Kippax, S., Horn, G., Kennedy, M., Hussey, G. & Batrouney, C. (2006). Gay community Periodic Survey Melbourne 2005. <strong>National</strong> Centre in HIV Social Research, <strong>National</strong> Centre in HIV Epidemiology and Clinical Research and Victorian AIDS Council/Gay Men’s Health Centre, <strong>National</strong> Centre in HIV Social Research. Hull, P., Rawstorne, P., Prestage, G., Crawford, J., Kippax, S., Sutherland, R., McGuigan, D. & Honnor, G. (2006a). Sydney Gay Community Periodic Survey February 1996 to August 2005. <strong>National</strong> Centre in HIV Social Research, <strong>National</strong> Centre in HIV Epidemiology and Clinical Research and The University of New South Wales, <strong>National</strong> Centre in HIV Social Research.
- Page 1:
National Amphetamine-Type Stimulant
- Page 4 and 5:
ii Acknowledgments This research wo
- Page 6 and 7:
iv Table of contents Acknowledgemen
- Page 8 and 9:
vi List of tables Table 1.1: Amphet
- Page 10 and 11:
viii
- Page 12 and 13:
2 The NDS framework and the Law Enf
- Page 14 and 15:
4 Table 1.1: Amphetamine-type stimu
- Page 16 and 17:
6 particularly on the Pacific Coast
- Page 18 and 19:
8 Figure 1.1: MDMA (ecstasy) tablet
- Page 20 and 21:
10 a 10-year period. While some of
- Page 22 and 23:
12 Figure 1.4: Forms of methampheta
- Page 24 and 25:
14 Figure 1.5: Median purity of met
- Page 26 and 27:
16 As noted, the route of administr
- Page 28 and 29:
18 Chapter 2: Setting the Context T
- Page 30 and 31:
20 Figure 2.2: Prevalence of ecstas
- Page 32 and 33:
22 19 years (Dunn et al., 2007). Th
- Page 34 and 35:
24 The use of MDMA among police det
- Page 36 and 37:
26 this survey is conducted with th
- Page 38 and 39:
28 models might be useful. On the o
- Page 40 and 41:
30 the questionnaire in February 20
- Page 42 and 43:
32 2.5 Summary According to the lat
- Page 44 and 45:
34 anxiety, agitation, tremor, teet
- Page 46 and 47:
36 may be stronger than the link wi
- Page 48 and 49:
38 Srisurapanot and colleagues (200
- Page 50 and 51:
40 Psychiatric problems appear to o
- Page 52 and 53:
42 In 2005, there was a total of 68
- Page 54 and 55:
44 The most recent EDRS survey foun
- Page 56 and 57:
46 same reasons they use the drugs
- Page 58 and 59:
48 Shoptaw and Reback (2007) review
- Page 60 and 61:
50 It has also been speculated that
- Page 62 and 63:
52 Parental ATS use In addition to
- Page 64 and 65:
54 The Minnesota Department of Heal
- Page 66 and 67:
56 Chapter 4: Prevention and Harm R
- Page 68 and 69:
58 should cover the full range of d
- Page 70 and 71:
60 specific drug (Spoth et al., 200
- Page 72 and 73:
62 be applied regularly and systema
- Page 74 and 75:
64 Strategies targeting vulnerable
- Page 76 and 77:
66 Examples of particular periods t
- Page 78 and 79:
68 At-risk workplaces There is incr
- Page 80 and 81:
70 The consultation forum with Abor
- Page 82 and 83:
72 young people was noted in the su
- Page 84 and 85:
74 and/or others); mental health ef
- Page 86 and 87:
76 of the fact that frequently peop
- Page 88 and 89:
78 Sexual risk behaviour is a furth
- Page 90 and 91:
80 • Cleaning up; • Transport o
- Page 92 and 93:
82 Assessing the risks of illicitly
- Page 94 and 95:
84 4.4 Challenges of applying preve
- Page 96 and 97:
86 but a number of studies are now
- Page 98 and 99:
88 The pack included a video, train
- Page 100 and 101:
90 Chapter 5: Treatment and Service
- Page 102 and 103:
92 to the occurrence of amphetamine
- Page 104 and 105:
94 In relation to the need for spec
- Page 106 and 107:
96 These studies replicate earlier
- Page 108 and 109:
98 addressed not only the drug user
- Page 110 and 111:
100 Research conducted in the subse
- Page 112 and 113:
102 users, data that may be general
- Page 114 and 115:
104 that limit brain exposure to me
- Page 116 and 117:
106 only significant difference was
- Page 118 and 119:
108 through the use of antipsychoti
- Page 120 and 121:
110 to develop the capacity of the
- Page 122 and 123: 112 It was also suggested that link
- Page 124 and 125: 114 as new evidence emerges. New ps
- Page 126 and 127: 116 border in 2000 (McKetin et al.,
- Page 128 and 129: 118 Table 6.1: Number of clandestin
- Page 130 and 131: 120 Table 6.2: Examples of domestic
- Page 132 and 133: 122 Tasmania In 2004, strengthened
- Page 134 and 135: 124 Recommendations from the consul
- Page 136 and 137: 126 Although there are a number of
- Page 138 and 139: 128 illegal drugs. When incarcerate
- Page 140 and 141: 130 heroin) (Payne et al., 2007). I
- Page 142 and 143: 132 Some examples of diversion prog
- Page 144 and 145: 134 Other research has compared psy
- Page 146 and 147: 136 Rehabilitation in Corrections T
- Page 148 and 149: 138 Synthetic Drugs measure will im
- Page 150 and 151: 140 • Stealing from motor vehicle
- Page 152 and 153: 142 criminal offences There continu
- Page 154 and 155: 144 • Increase international coll
- Page 156 and 157: 146 • Ensuring offence and penalt
- Page 158 and 159: 148 Law enforcement agencies are pl
- Page 160 and 161: 150 Appendix 1 National consultatio
- Page 162 and 163: 152 Appendix 2 Written submissions
- Page 164 and 165: 154 Australian Institute of Health
- Page 166 and 167: 156 Bowers, J. & Johnson, S. (2003)
- Page 168 and 169: 158 Crits-Christoph, P., Siqueland,
- Page 170 and 171: 160 Drug & Alcohol Services South A
- Page 174 and 175: 164 Hull, P., Rawstorne, P., Zablot
- Page 176 and 177: 166 Leek, L., Seneque, D., & Ward,
- Page 178 and 179: 168 McKetin, R., McLaren, J., Kelly
- Page 180 and 181: 170 NSW Health (2006). Psychostimul
- Page 182 and 183: 172 Ressler, K.J., & Nemeroff, C.B.
- Page 184 and 185: 174 Small, W., Kerr, T., Charette,
- Page 186 and 187: 176 United Nations Office for Drug
- Page 188 and 189: 178
- Page 190: 180